Nasdaq stss.

Apr 19, 2022 · The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ... NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...On Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.4,365.98 Home STSS • NASDAQ Sharps Technology Inc Follow Share $0.44 Nov 6, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Innovative Eyewear Inc $0.44 LUCY3.33% Bruush Oral...

The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ... Find the latest Insider Activity data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.

Feb 6, 2023 · NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medical device company Sharps Technology (NASDAQ:STSS) is enjoying a massive su...By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and researchSTSS Sharps Technology Inc Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ...NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies Stocks

STSS Sharps Technology Inc Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article

SHIFTPIXY INC ( NASDAQ:PIXY) has an unusual volume of 4.51M shares today. NASDAQ:PIXY is declining 23.81% today. The average daily volume over 50 days is 3.33M, so this is 35.59% above the average volume. With 16.2M shares traded so far, FEMASYS INC ( NASDAQ:FEMY) is experiencing an unusual level of activity today.Explore Sharps Technology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.Explore Sharps Technology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.Sep 27, 2023 · NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ... At Cannae Holdings, a filing with the SEC revealed that on Monday, Director Barry B. Moullet bought 1,000 shares of CNNE, for a cost of $23.06 each, for a total investment of $23,064. So far ...

If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a...Nov 10, 2023 · Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ... What's going on at Sharps Technology (NASDAQ:STSS)? Read today's STSS news from trusted media outlets at MarketBeat.NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...

Sharps Technology Inc. Warrant (STSSW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

STSS Sharps Technology Inc Form 4 - Statement of changes in beneficial ownership of securities. SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF ...Explore Sharps Technology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ...06/30/2022. 26. 26. New. $0. 1. Back to STSS Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ...By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and researchFind the latest Revenue & EPS data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. markets.businessinsider.com - September 15 at 10:14 AM. Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying. benzinga.com - September 10 at 7:40 AM. Multiple insiders bought Sharps Technology, Inc. (NASDAQ:STSS) stock earlier this year, a positive sign for shareholders. finance.yahoo.com - July 15 at 8:36 AM.See the latest Sharps Technology Inc stock price (STSS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Sep 29, 2023 · ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American ... May 9, 2023 · The firm decreased its portfolio allocation in STSS by 64.58% over the last quarter. Empery Asset Management holds 830K shares representing 7.12% ownership of the company. No change in the last ...

BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine …

Nov 28, 2023 · Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe ...

In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. What are individual investors saying about Sharps Technology? View the latest STSS social media trends at MarketBeat.Find the latest Revenue & EPS data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. (STSS) raised $16 million in an initial public offering on Thursday, April 14th 2022. The company issued 3,750,000 shares at a price of $4.25 per share. Who are Sharps Technology's major shareholders?NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Aug 1, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. 0001737995 false 0001737995 2023-07-27 2023-07-27 0001737995 STSS:CommonStock0.0001P... Monitor; Quote; Level 2; Movers ... 08.06.2022 - NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) - Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented ...InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medical device company Sharps Technology (NASDAQ:STSS) is enjoying a massive su...STSS Sharps Technology Inc Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature ArticleIn-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. What are individual investors saying about Sharps Technology? View the latest STSS social media trends at MarketBeat.

STSS Stock Overview Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe …View real-time STSS stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ...Sharps technology director timothy ruemler buys 15k common shares nov. 22, 2023 for $6.2k. Sharps technology disclosed on tuesday the director bought 15k shares at an average price of $0.41/share for $5.6m. Silo pharma shares increased by 36.2% to $2.22 during tuesday's pre-market session. Tracon pharma (nasdaq:tcon) shares rose by 30.02%.Instagram:https://instagram. trowe price capital appreciation fundefc stock dividendtop options brokershow to calculate call option profit Fintel reports that on May 9, 2023, Aegis Capital initiated coverage of Sharps Technology (NASDAQ:STSS) with a Buy recommendation.US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. dino sinclairvalue of jfk half dollars Nov 17, 2023 · Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces an update on commercialization activities and is highlighted in Med Tech Outlook feature article. companies in the dow Sharps Technology, Inc. (NASDAQ:STSS Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 171,000 shares, a decline of 47.6% from the May 31st total of 326,600 shares. Based on an average daily volume of 937,100 shares, the ... STSS: Get the latest Sharps Technology stock price and detailed information including STSS news, historical charts and realtime prices. Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. ...